These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8669877

  • 1. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y, Shisa H, Uehara T, Kurosumi M, Kobayashi Y, Tanuma J, Shiromizu K, Matsuzawa M, Kishi K.
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [Abstract] [Full Text] [Related]

  • 2. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
    Ota T, Gilks CB, Longacre T, Leung PC, Auersperg N.
    Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

  • 5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG.
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic and biological determinants in undifferentiated and poorly differentiated ovarian carcinomas.
    Canzonieri V, Viel A, Visentin MC, Perin T, Sopracordevole F, Dall'Agnese L, Scara-Belli C, Boiocchi M, Carbone A.
    Pathologica; 1995 Oct; 87(5):492-7. PubMed ID: 8868173
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C, Bratthauer GL, Barner R, Vang R.
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [Abstract] [Full Text] [Related]

  • 8. Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin.
    Kuwashima Y, Uehara T, Kurosumi M, Kishi K, Shiromizu K, Matsuzawa M, Takayama S.
    Eur J Gynaecol Oncol; 1995 Sep; 16(3):181-6. PubMed ID: 7664763
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y, Yamashita K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [Abstract] [Full Text] [Related]

  • 10. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R.
    Anticancer Res; 1997 Sep; 17(1B):613-9. PubMed ID: 9066588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M, Fujii H, Kinezaki M, Morita Y, Nanno H, Yoshida M.
    Anticancer Res; 2001 Sep; 21(4B):2925-32. PubMed ID: 11712788
    [Abstract] [Full Text] [Related]

  • 14. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
    Kuwata T, Kitagawa M, Takemura T, Hirokawa K.
    Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593
    [Abstract] [Full Text] [Related]

  • 15. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D, Hirschmann A, Löhrs U, Diebold J.
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [Abstract] [Full Text] [Related]

  • 16. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
    Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA.
    J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
    Sato S, Okamoto S, Ito K, Konno R, Yajima A.
    Acta Cytol; 2000 Oct; 44(3):485-8. PubMed ID: 10834020
    [No Abstract] [Full Text] [Related]

  • 20. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K, McCluggage WG, Ordonez NG, Euscher ED, Malpica A, Sneige N, Silva EG, Deavers MT.
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.